Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Preclinical | China | 22 Sep 2025 | |
| Bladder Cancer | Preclinical | China | 17 Aug 2025 | |
| Bladder Cancer | Preclinical | China | 17 Aug 2025 |





